• image
  • li>image
  • image
  • image
  • image
  • image
  • image
  • image

Main Menu



Vice president, Yi-Ming (Arthur) Chen

Home > Administration > Vice president, Yi-Ming (Arthur) Chen


Vice president, Yi-Ming (Arthur) Chen, M.D., Sc. D.



Yi-Ming (Arthur) Chen








Faculty of Medicine, National Yang-Ming University




Institute of Microbiology and Immunology, National Yang-Ming University(NYMU)




Department of Cancer Biology, Harvard School of Public Health, Boston, MA, USA








Positions Held:




Dean, Office of Research and Development, National Yang-Ming University




Director, Main Research Center, National Yang-Ming University




Director, Program in International Health, National Yang-Ming University




Dean, Office of International Affairs , National Yang-Ming University




Director, Center for International Academic Cooperation, National Yang-Ming University




Distinguished Professor, National Yang-Ming University




Professor, Department of Microbiology and Immunology, National Yang-Ming University




Co-Hiring Professor, Institute of Microbiology and Immunology, National Yang-Ming University




Co-Hiring Professor, Institute of Clinical Medicine, National Yang-Ming University




Co-Hiring Professor, Institute of Brain Science, National Yang-Ming University


2002 Oct -2003 Feb


Visiting Scientist, HIV Drug Resistance Program, NCI, NIH, USA




Professor(2000-2005 Chairman), Institute of Public Health, National Yang-Ming University




Associate Research Member, Institute of Biomedical Sciences, Academia Sinica




Associate Professor(1994-1997 Chairman), Institute of Public Health, National Yang-Ming University






Education and Culture Award, Significant Contribution to the Scientific Education for the Public, from the Ministry of Education, 1993.


Research award, from the National Science Council, 1993, 1994, 1995, 1997, 1999 and 2000.


Young Investigator Award, First Joint Annual Conference of the Society of Oncology, 1996.


Scholarships from the National Science of Council of ROC for short-term training, 2003.


Outstanding alumnus, Fu-Xin Primary school , 2004.


Best Paper Award from the Urbani Foundation 2005 and 2007.


Award to Special contribution to harm reduction program, 2007, Ministry of Health.


Outstanding Research Award from National Science Council, 2008.


Outstanding alumnus (Academic achievement), National Yang-Ming University, 2009


The 8th National Innovation Award (國家新創獎) in the Academic Research Category by Institute for Biotechnology and Medicine Industry, 2011.


Award of the “Science Tour-Health Research in ” from German Academic Exchange Service, 2011.


Vice president:


Professor Yi-Ming Arthur Chen currently serves as the vice president of Kaohsiung Medical University (KMU). He is also a distinguished professor of Institute of Medical Research of KMU. Professor Chen received his M.D. from National Yang-Ming University (NYMU) in 1982, M.S. from Graduate Institute of Microbiology and Immunology of NYMU in 1984. He went to Boston to study at Harvard School of Public Health after he finished his military service in 1986. It took less than 4 years for him to finish his Doctor of Science (Sc.D.) program under the mentorship of Professor Max Essex at the Department of Cancer Biology. Then, he went to National Cancer Institute in Frederick, Maryland to receive his post-doctoral training in the Dr. Takes Papas’ Lab of Molecular Oncology. In 1992, Dr. Chen came back to Taiwan and got a joined appointment from Institute of Biomedical Sciences, Academia Sinica and Department of Public Health of NYMU. Since then, he has served different administrative positions for NYMU including Chairman of Department of Public Health (1994-97; 2000-2005), Dean of International Affairs (2007-10), Director of International Health Program (2008-10), Dean of R & D and Director of General Research Center (2010-11). In early 2013 Dr. Chen moved his whole lab to KMU and established Center for Infectious Disease and Cancer Research (CICAR).


   Dr. Chen focuses his research on HIV/AIDS and cancer. He has published more than 130 SCI papers in high ranked journals including Lancet, Hepatology, PNAS, Journal of Virology, Journal of AIDS and Int.J Cancer, Clinical Infectious Dieseaes and J Infect Dis and received many awards. Besides, he had 7 patents from his study on liver cancer biomarkers and animal models. Dr. Chen also served in many important advisory committees in the National Science Council, Ministriry of Health and Welfare, and Ministry of Education.


    Dr. Chen devotes himself in the global health, especially in the prevention and treatment program for HIV/AIDS and cancer. He participated in many international and domestic non-governmental organizations including APCASO (Asia Pacific AIDS Services Organization), TREAT Asia and Taiwan Society of Preventive Medicine. He is also the founder and chairman of Taiwan Harm Reduction Association. 





United States Patent: Detection and Correction of Abnormalities of Cells having Decreased Levels of Glycine N-methyltransferase. Patent number: 5994093 (1999/11/30-Nov. 30, 2019/11/29).


ROC Patent: Detection and Correction of Abnormalities of Cells having Decreased Levels of Glycine N-methyltransferase. Patent number: 086114505  (Duration: 1997/10/4-Oct. 4, 2017/10/3).


United States Patent: Glycine N-methyltransferase monoclonal antibodies and methods of use therefore. Patent number: 7176291 (Duration: 2007/2/13-2027/2/12).


United States Patent: Glycine N- methyltransferase (GNMT) animal model and use thereof. Patent number: US7759542 (Duration: 2007/8/1-2027/7/31).


China Patent:甘氨酸N-甲基轉移酶在製備預防或治療黃麴霉素所引發的疾病的藥物中的應用. Patent number: 200810008673.6 (Duration: Jan. 29, 2008/1/29- 2027/1/28).


US, Europe and ROC patents: A mouse model for depression, schizophrenia and Alzheimer’s disease.




Selected papers related to “Infectious Disease” or “Cancer” from more than 140 SCI publications:Infectious Diseases (HTLV-I, HIV-1, HCV, H5N1, Enterovirus and SARS)      more


Cancer (Liver and Prostatic Cancer):   more


Publications in the past 5 years (2009-2014):   more